Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 3Glioblastoma 3Brain Neoplasms 3Astrocytoma 3Oligodendroglioma 2Glioma 2Central Nervous System Neoplasms 2Medulloblastoma 1Familial ependymoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Temozolomide 14Filgrastim 13Magnetic Resonance Spectroscopy 9Cyclophosphamide 7Carboplatin 7Peripheral Blood Stem Cell Transplantation 6Irinotecan 6Granulocyte Colony-Stimulating Factor 6Etoposide 6X-Rays 5Topotecan 5Thiotepa 5Phantoms, Imaging 5Busulfan 5Biopsy 5Specimen Handling 4Radiotherapy 4Nuclear Medicine Department, Hospital 4Melphalan 4Ifosfamide 4sargramostim 3palbociclib 3olaparib 3etoposide phosphate 3Surgical Procedures, Operative 3Paclitaxel 3ulixertinib 2trioctyl phosphine oxide 2tipifarnib 2tazemetostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × Genetic Therapy × Sarcoma × Clear all
NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Indiana University

Phase 1 Completed
10 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡